Literature DB >> 17064398

Actinobacillus actinomycetemcomitans lipopolysaccharide induces interleukin-6 expression through multiple mitogen-activated protein kinase pathways in periodontal ligament fibroblasts.

C Patil1, C Rossa, K L Kirkwood.   

Abstract

Actinobacillus actinomycetemcomitans plays a major role in the pathogenesis of aggressive periodontitis. Lipopolysaccharide (LPS) derived from A. actinomycetemcomitans is a key factor in inflammatory cytokine generation within periodontal tissues. In this study, we identify major mitogen-activated protein kinase (MAPK) signaling pathways induced by A. actinomycetemcomitans LPS, Escherichia coli LPS and interleukin-1beta (IL-1beta) in a murine periodontal ligament (mPDL) fibroblast cell line. Immunoblot analysis was used to assess the phosphorylated forms of p38, extracellular-regulated kinase (ERK) and c-jun N-terminal kinase (JNK) MAPK following stimulation with A. actinomycetemcomitans LPS, E. coli LPS and IL-1beta. IL-6 mRNA induction was detected via reverse transcription-polymerase chain reaction, while protein levels were quantified via enzyme-linked immunosorbent assays (ELISA). We utilized biochemical inhibitors of p38, ERK and JNK MAPK to identify the MAPK signaling pathways needed for IL-6 expression. Additional use of stable mPDL cell lines containing dominant negative mutant constructs of MAPK kinase-3 and -6 (MKK-3/6) and p38 null mutant mouse embryonic fibroblast (MEF) cells were used to substantiate the biochemical inhibitor data. Blocking p38 MAPK with SB203580 reduced the induction of IL-6 mRNA by A. actinomycetemcomitans LPS, E. coli LPS and IL-1beta by >70%, >95% and approximately 60%, respectively. IL-6 ELISA indicated that blocking p38 MAPK reduced the IL-6 protein levels induced by A. actinomycetemcomitans LPS, E. coli LPS and IL-1beta by approximately 60%, approximately 50% and approximately 70%, respectively. All MAPK inhibitors significantly reduced the IL-6 protein levels induced by A. actinomycetemcomitans LPS, E. coli LPS and IL-1beta whereas only p38 inhibitors consistently reduced the A. actinomycetemcomitans LPS, E. coli LPS and IL-1beta induction of IL-6 mRNA steady-state levels. The contribution of p38 MAPK LPS-induced IL-6 expression was confirmed using MKK-3/6 dominant negative stable mPDL cell lines. Wild-type and p38alpha(-/-) MEF cells provided additional evidence to support the role of p38alpha MAPK in A. actinomycetemcomitans LPS-stimulated IL-6. Our results indicate that induction of IL-6 by E. coli LPS, IL-1beta and A. actinomycetemcomitans LPS requires signaling through MKK-3-p38alpha ERK, JNK and p38 MAPK in mPDL cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17064398     DOI: 10.1111/j.1399-302X.2006.00314.x

Source DB:  PubMed          Journal:  Oral Microbiol Immunol        ISSN: 0902-0055


  21 in total

1.  Porphyromonas gingivalis-derived lipopolysaccharide-mediated activation of MAPK signaling regulates inflammatory response and differentiation in human periodontal ligament fibroblasts.

Authors:  Taegun Seo; Seho Cha; Tae-Il Kim; Jeong-Soon Lee; Kyung Mi Woo
Journal:  J Microbiol       Date:  2012-04-27       Impact factor: 3.422

Review 2.  Beyond good and evil in the oral cavity: insights into host-microbe relationships derived from transcriptional profiling of gingival cells.

Authors:  M Handfield; H V Baker; R J Lamont
Journal:  J Dent Res       Date:  2008-03       Impact factor: 6.116

Review 3.  Herpesvirus-bacteria synergistic interaction in periodontitis.

Authors:  Casey Chen; Pinghui Feng; Jørgen Slots
Journal:  Periodontol 2000       Date:  2020-02       Impact factor: 7.589

4.  Heritability of periodontal bone loss in mice.

Authors:  S Hiyari; E Atti; P M Camargo; E Eskin; A J Lusis; S Tetradis; F Q Pirih
Journal:  J Periodontal Res       Date:  2015-01-12       Impact factor: 4.419

5.  Hypoxia augments lipopolysaccharide-induced cytokine expression in periodontal ligament cells.

Authors:  Congxiang Jian; Chenjun Li; Yu Ren; Yong He; Yunming Li; Xiaodan Feng; Gang Zhang; Yinghui Tan
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

6.  A Chemically Modified Curcumin (CMC 2.24) Inhibits Nuclear Factor κB Activation and Inflammatory Bone Loss in Murine Models of LPS-Induced Experimental Periodontitis and Diabetes-Associated Natural Periodontitis.

Authors:  Muna S Elburki; Carlos Rossa; Morgana R Guimarães-Stabili; Hsi-Ming Lee; Fabiana A Curylofo-Zotti; Francis Johnson; Lorne M Golub
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

7.  Functionalized nanoparticles containing MKP-1 agonists reduce periodontal bone loss.

Authors:  Michael S Valerio; Frank Alexis; Keith L Kirkwood
Journal:  J Periodontol       Date:  2019-03-13       Impact factor: 6.993

Review 8.  The potential of p38 MAPK inhibitors to modulate periodontal infections.

Authors:  Keith L Kirkwood; Carlos Rossa
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

9.  A Murine Model of Lipopolysaccharide-Induced Peri-Implant Mucositis and Peri-Implantitis.

Authors:  Flavia Q Pirih; Sarah Hiyari; Ho-Yin Leung; Ana D V Barroso; Adrian C A Jorge; Jeniffer Perussolo; Elisa Atti; Yi-Ling Lin; Sotirios Tetradis; Paulo M Camargo
Journal:  J Oral Implantol       Date:  2014-06-26       Impact factor: 1.779

10.  Targeting mRNA stability arrests inflammatory bone loss.

Authors:  Chetan S Patil; Min Liu; Wenpu Zhao; Derek D Coatney; Fei Li; Elizabeth A VanTubergen; Nisha J D'Silva; Keith L Kirkwood
Journal:  Mol Ther       Date:  2008-08-05       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.